Current Cancer Drug Targets logo Bentham Science Publishers logo

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 1, Number 3, November 2001
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Book Reviews

Preface
pp. i-i(1)
Author: Zhang R.

Reviews

Antisense Anticancer Oligonucleotide Therapeutics
pp. 177-196(20)
Authors: Wang H.; Prasad G.; Buolamwini J.K.; Zhang R.

Antisense and / or Immunostimulatory Oligonucleotide Therapeutics
pp. 197-209(14)
Authors: Agrawal S.; Kandimalla E.R.

Targeting of Cancer-Related Proteins with PNA Oligomers
pp. 231-239(10)
Authors: Pooga M.; Langel U.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A